ARTbio Partners with 3B Pharma for Alpha Radioligand Therapy
14 Nov 2024 //
PR NEWSWIRE
ARTBIO Partners with 3B Pharma on Alpha Radioligand for Tumors
13 Nov 2024 //
PR NEWSWIRE
RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharma
20 Sep 2023 //
BUSINESSWIRE
Pan-Cancer Analysis Suggests FAP for Peptide-Targeted Radionuclide Therapy
07 Oct 2021 //
BUSINESSWIRE